daratumumab,carfilzomib,pomalidomide,dexamethasone
janssen,amgen
['daratumumab', 'multiple myeloma']
#asco22 | poster 436 | sat 4:30pm cdt
a phase ii study of daratumumab with weekly carfilzomib, pomalidomide, and dexamethasone in relapsed and refractory multiple myeloma.
presenter: andrew yee, md ( ) 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.